Variation of treatment planning parameters (D90 HR-CTV, D2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: Comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints

被引:47
|
作者
Jurgenliemk-Schulz, Ina M. [1 ]
Lang, Stefan [2 ]
Tanderup, Kari [3 ]
de Leeuw, Astrid [1 ]
Kirisits, Christian [2 ]
Lindegaard, Jacob [3 ]
Petric, Primoz [4 ]
Hudej, Robert [4 ]
Poetter, Richard [2 ]
机构
[1] Univ Med Ctr Utrecht, Dept Radiat Oncol, Utrecht, Netherlands
[2] Med Univ Vienna, Dept Radiotherapy, A-1090 Vienna, Austria
[3] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
[4] Inst Oncol, Dept Radiotherapy, Ljubljana, Slovenia
关键词
Treatment planning; Brachytherapy; Gynaecological; MRI based; Multicentre; INTRACAVITARY BRACHYTHERAPY; WORKING GROUP; INTERSTITIAL BRACHYTHERAPY; ASSISTED BRACHYTHERAPY; ADAPTIVE BRACHYTHERAPY; HDR-BRACHYTHERAPY; PDR BRACHYTHERAPY; VIENNA APPLICATOR; REFERENCE-POINT; CARCINOMA;
D O I
10.1016/j.radonc.2009.10.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To perform a qualitative and quantitative comparison of different treatment planning methods used in different centres for MRI-based brachytherapy (BT) of cervical cancer. Materials and methods: Two representative patients with advanced cervical cancer (I "limited volume case"; 1 "extensive volume case") were planned for brachytherapy (BT) with a tandem-ring applicator by six different centres. During a workshop all centres produced an institutional standard plan and an MRI-based adaptive treatment plan for each case. Optimisation was based on the fractionation schedule (HDR, PDR) and method according to the institutional protocol. Results: The loading pattern, dwell times, shape of the point A isodose varied considerably between institutional standard plans, as did dose-volume parameters for high risk CTV (HR-CTV) and also for the D-2cc for OAR, violating the dose-volume constraints in many situations. During optimisation, the centres stayed as close as possible to the standard loading pattern and dwell times. The dose distributions and dose-volume parameters between the plans from the different centres became much more comparable after optimisation. The prescribed dose to the HR-CTV could be achieved in the limited volume case by all centres, in the extensive case only if additional needles were applied. Conclusion: Treatment planning for gynaecologic brachytherapy based on different traditions shows less variation in regard to target coverage and OAR dose, when 3D image-based optimisation is performed with a uniform prescription protocol. (C) 2009 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 94 (2010) 339-345
引用
收藏
页码:339 / 345
页数:7
相关论文
共 5 条
  • [1] Factors affecting D90 HR-CTV of 3D image-based brachytherapy in locally advanced cervical cancer
    Chitmanee, Paramintra
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S271 - S272
  • [2] DOSE AND VOLUME PARAMETERS FOR CT BASED TREATMENT PLANNING IN INTRACAVITARY BRACHYTHERAPY FOR CERVICAL CANCER. A COMPARISON BETWEEN 2D AND 3D BRACHYTHERAPY
    Enciu, Lucia Elena
    Constantinescu, Amalia
    Savu, Mircea
    Baranga, Gabriel
    Oprea, Alexandru
    Croitoriu, Madalina
    Busuioc, Laurentiu
    ROMANIAN REPORTS IN PHYSICS, 2018, 70 (02)
  • [3] DOSIMETRIC ANALYSIS OF 3D IMAGE-GUIDED HDR BRACHYTHERAPY PLANNING FOR THE TREATMENT OF CERVICAL CANCER: IS POINT A-BASED DOSE PRESCRIPTION STILL VALID IN IMAGE-GUIDED BRACHYTHERAPY?
    Kim, Hayeon
    Beriwal, Sushil
    Houser, Chris
    Huq, M. Saiful
    MEDICAL DOSIMETRY, 2011, 36 (02) : 166 - 170
  • [5] Recommendations from gynaecological (GYN) GEC ESTRO working group (II):: Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy -: 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiotogy
    Pötter, R
    Haie-Meder, C
    Van Limbergen, E
    Barillot, I
    De Brabandere, M
    Dimpoulos, J
    Dumas, I
    Erickson, B
    Lang, S
    Nulens, A
    Petrow, P
    Rownd, J
    Kirisits, C
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 (01) : 67 - 77